These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23990085)

  • 1. [Molecular surveillance shows progress in measles elimination process].
    Santibanez S; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1238-42. PubMed ID: 23990085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the elimination of measles and rubella in the WHO European Region].
    Muscat M; Jankovic D; Goel A; Butler R; Pfeifer D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1225-30. PubMed ID: 23990083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hot spot: epidemiology of measles and rubella in Germany and the WHO European region].
    Matysiak-Klose D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1231-7. PubMed ID: 23990084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measles in Germany: An Epidemiological Analysis and First Measures for Containment].
    Matysiak-Klose D; Wicker S;
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1767-1772. PubMed ID: 29145682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow Progress In Finalizing Measles And Rubella Elimination In The European Region.
    Biellik R; Davidkin I; Esposito S; Lobanov A; Kojouharova M; Pfaff G; Santos JI; Simpson J; Mamou MB; Butler R; Deshevoi S; Huseynov S; Jankovic D; Shefer A
    Health Aff (Millwood); 2016 Feb; 35(2):322-6. PubMed ID: 26858387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The State of Measles and Rubella in the WHO European region.
    Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R
    Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents].
    Poethko-Müller C; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1243-52. PubMed ID: 23990086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Must we expect an epidemic of measles in the near future in Southern Tyrol?].
    Kreidl P; Morosetti G
    Wien Klin Wochenschr; 2003; 115 Suppl 3():55-60. PubMed ID: 15508782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO European Region's strategy for elimination of measles and congenital rubella infection.
    Hanon FX; Spika John J; Wassilak Steven S; Emiroglu N
    Euro Surveill; 2003 Jun; 8(6):129-30. PubMed ID: 12878802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of epidemiological studies for progress of measles elimination].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe].
    Garcés-Sánchez M; Renales-Toboso M; Bóveda-García M; Díez-Domingo J
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):673-8. PubMed ID: 26611100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.
    Choe YJ; Jee Y; Oh MD; Lee JK
    J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S115-21. PubMed ID: 26617443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress towards measles elimination -South-East Asia Region, 2003-2013.
    Wkly Epidemiol Rec; 2015 Jun; 90(24):297-305. PubMed ID: 26072524
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress towards measles elimination, Philippines, 1998–2014.
    Wkly Epidemiol Rec; 2015 Apr; 90(15):149-59. PubMed ID: 25864232
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.